Predicting prostate cancer: Pitt-developed test identifies new methods for treatment

September 15, 2014 4:01 PM

2 0

PITTSBURGH, Sept. 15, 2014 – A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment.

The analysis, published today in the American Journal of Pathology, found that prostate cancer patients who carry certain genetic mutations have a 91 percent chance of their cancer recurring. This research was funded by the National Institutes of Health (NIH), American Cancer Society and University ...

Read more

To category page